anticancer therapeutic (Biota/Hitachi/Nippon)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanticancer therapeutic (Biota/Hitachi/Nippon)
Drug Alias Nameprostate cancer therapeutic (Biota/Hitachi/Nippon)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesResonac Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A